Amlodipine Besylate Tablet
Product Images NDC 70518-0835

7 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 70518-0835). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of amlodipine besylate showing its molecular framework with labeled atoms and bonds, including chlorine, nitrogen, oxygen, sulfur, and carbon elements represented in the diagram.*
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
A Kaplan-Meier curve chart depicting event rates over 24 months comparing Amlodipine and Placebo groups. The x-axis shows time in months, and the y-axis shows the event rate. The graph includes annotations of p-value (0.003), hazard ratio (0.691), and 95% confidence interval (0.54, 0.88). Amlodipine shows a lower event rate than Placebo over time with numbers at risk displayed below the timeline.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A forest plot chart showing hazard ratio comparisons with 95% confidence intervals for various patient subgroups treated with Amlodipine versus placebo. Subgroups include all patients, age, gender, baseline sitting systolic blood pressure, baseline vessel disease, vessels with stenosis, and PCI stent strata. The x-axis represents hazard ratio from 0.0 to 2.0, indicating the effect favoring Amlodipine or placebo.*
FDA Label Image

Mm1 (Amlodipine Besylate 5mg 70518 0835 00)

Mm1 (Amlodipine Besylate 5mg 70518 0835 00)
Label for Amlodipine Besylate oral tablets, 5 mg strength. The package contains 30 round white tablets. Labeler is Remedy Repack Inc., with repackaging site in Indiana, PA. Original manufacturer Cipla USA, Inc., Warren, NJ. Includes storage instructions and a QR code.*
FDA Label Image

Mm2 (Amlodipine Besylate 5mg 70518 0835 01)

Mm2 (Amlodipine Besylate 5mg 70518 0835 01)
A medication label for Amlodipine Besylate 5 mg tablets in a quantity of 90 tablets. The label displays the NDC number 70518-0835-01 and notes the tablets are round, white, and size 127C. It is labeled as RX only and repackaged by RemedyRepack Inc., Indiana, PA. Storage instructions recommend temperatures between 20-25°C with permitted excursions to 15-30°C.*
FDA Label Image

Mm3 (Amlodipine Besylate 5mg 70518 0835 02)

Mm3 (Amlodipine Besylate 5mg 70518 0835 02)
A packaging label for Amlodipine Besylate 5 mg oral tablets. The label indicates a quantity of 100 tablets and includes the NDC number 70518-0835-02. It states the tablets are round and white. The label shows the manufacturer as Cipla USA, Inc., located in Warren, NJ, and the repackager as RemedyRepack Inc. in Indiana, PA.*
FDA Label Image

Mm4 (Amlodipine Besylate 5mg 70518 0835 03)

Mm4 (Amlodipine Besylate 5mg 70518 0835 03)
Label for Amlodipine Besylate 5 mg tablets, quantity 30, NDC 70518-0835-03, repackaged by RemedyRepack Inc. The label includes storage instructions, manufacturer details (Cipla USA, Inc.), and a QR code. The tablets are described as round and white.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.